{"log_id": 3277183166420862305, "direction": 0, "words_result_num": 42, "words_result": [{"probability": {"variance": 0.004221, "average": 0.984753, "min": 0.641799}, "location": {"width": 603, "top": 190, "height": 33, "left": 214}, "words": "在配制药液过程中,使川带排气孔的注射针头,也可减少气的形成"}, {"probability": {"variance": 0.001317, "average": 0.981931, "min": 0.821277}, "location": {"width": 736, "top": 223, "height": 33, "left": 265}, "words": "配制甲氨蝶吟所有物品或和体有关的废物应装入双层密封的聚乙烯口袋中,在"}, {"probability": {"variance": 0.022808, "average": 0.928464, "min": 0.532897}, "location": {"width": 121, "top": 257, "height": 22, "left": 217}, "words": "1100℃下焚化"}, {"probability": {"variance": 0.000149, "average": 0.987009, "min": 0.965367}, "location": {"width": 105, "top": 285, "height": 26, "left": 213}, "words": "泄漏和处置"}, {"probability": {"variance": 0.008033, "average": 0.949919, "min": 0.571671}, "location": {"width": 719, "top": 316, "height": 33, "left": 264}, "words": "如果发生泄漏,限制进入污区域,戴双层乳胶手套,呼吸面罩,防护罩衣和护目镜"}, {"probability": {"variance": 0.021431, "average": 0.918419, "min": 0.351343}, "location": {"width": 787, "top": 348, "height": 32, "left": 213}, "words": "用纸、“CHUX”、或细小碎酒来吸附泄物、防止共扩展。泄物也可用5%次氯酸钠处"}, {"probability": {"variance": 0.004699, "average": 0.971523, "min": 0.664601}, "location": {"width": 788, "top": 378, "height": 33, "left": 213}, "words": "理。从泄深区域收集的吸附性物质和碎屑,置于防漏的塑料容器中,贴上相应的标签。细胞"}, {"probability": {"variance": 0.037145, "average": 0.876175, "min": 0.386717}, "location": {"width": 768, "top": 407, "height": 35, "left": 212}, "words": "毒性废弃物作为有害和有毒物质,应明确标上“细胞海性废物,于1100℃下焚烧”字样"}, {"probability": {"variance": 0.028725, "average": 0.906684, "min": 0.45076}, "location": {"width": 787, "top": 441, "height": 31, "left": 213}, "words": "废弃物应在:1100℃下至少焚烧秒钟(废药瓶分解为H:O及C)。随后用大量的清水冲洗"}, {"probability": {"variance": 6.7e-05, "average": 0.994757, "min": 0.98065}, "location": {"width": 84, "top": 473, "height": 22, "left": 213}, "words": "污染区域"}, {"probability": {"variance": 0.018652, "average": 0.941011, "min": 0.531784}, "location": {"width": 232, "top": 532, "height": 29, "left": 219}, "words": "【孕妇及哺乳期如女用药】"}, {"probability": {"variance": 2e-06, "average": 0.999022, "min": 0.995072}, "location": {"width": 203, "top": 564, "height": 26, "left": 257}, "words": "怀孕期使用:D类药物"}, {"probability": {"variance": 0.012168, "average": 0.957651, "min": 0.509509}, "location": {"width": 740, "top": 595, "height": 33, "left": 260}, "words": "甲氨蝶呤可以引起死胎和或先天性畸形,因此本品不推荐用于可能怀孕的妇女,除非"}, {"probability": {"variance": 0.011722, "average": 0.947509, "min": 0.437144}, "location": {"width": 784, "top": 625, "height": 35, "left": 213}, "words": "有适当的医学证据证明潜在的瓶大于被评估的风险怀孕的银屑病患者不能接受甲氨蝶呤"}, {"probability": {"variance": 0.015539, "average": 0.956234, "min": 0.449737}, "location": {"width": 787, "top": 656, "height": 35, "left": 212}, "words": "治疗。有怀孕可能的妇女在排除怀孕之前不能使用甲氨蝶呤,并且要充分告知其如果在治"}, {"probability": {"variance": 0.01091, "average": 0.942475, "min": 0.693792}, "location": {"width": 283, "top": 689, "height": 25, "left": 211}, "words": "疗期间怀孕对胎儿有严重的风险"}, {"probability": {"variance": 0.000832, "average": 0.989855, "min": 0.831923}, "location": {"width": 740, "top": 720, "height": 33, "left": 257}, "words": "尽管甲氨蝶呤治疗停止与怀孕之间的最佳间隔时间还没有确定,但是配偶任意一方正"}, {"probability": {"variance": 0.001991, "average": 0.974169, "min": 0.84054}, "location": {"width": 522, "top": 751, "height": 30, "left": 212}, "words": "在接受甲氨蝶呤治疗或治疗结束后至少3个月内都应该避孕"}, {"probability": {"variance": 1.2e-05, "average": 0.996228, "min": 0.989977}, "location": {"width": 105, "top": 784, "height": 23, "left": 257}, "words": "哺乳期用药"}, {"probability": {"variance": 0.010579, "average": 0.954264, "min": 0.518728}, "location": {"width": 741, "top": 812, "height": 35, "left": 259}, "words": "甲氨蝶呤可以泌入母乳中,哺乳期禁川。甲氨蝶呤在母乳中的最高浓度与血清浓度的"}, {"probability": {"variance": 0.011842, "average": 0.956527, "min": 0.521962}, "location": {"width": 785, "top": 845, "height": 33, "left": 213}, "words": "比值可达到0.08:1、由于乳婴儿时存在米自母乳中的甲氨蝶呤产生严重副反应的潜在危"}, {"probability": {"variance": 0.004475, "average": 0.961331, "min": 0.776433}, "location": {"width": 304, "top": 877, "height": 25, "left": 211}, "words": "险,所以乳期妇女禁止使用本品"}, {"probability": {"variance": 0.000103, "average": 0.994108, "min": 0.9716}, "location": {"width": 109, "top": 937, "height": 24, "left": 220}, "words": "【儿童用药】"}, {"probability": {"variance": 0.001118, "average": 0.974172, "min": 0.905054}, "location": {"width": 282, "top": 970, "height": 24, "left": 260}, "words": "对于婴幼儿患者应慎用甲氨蝶呤"}, {"probability": {"variance": 2e-06, "average": 0.998106, "min": 0.995387}, "location": {"width": 110, "top": 1028, "height": 28, "left": 217}, "words": "【老年用药】"}, {"probability": {"variance": 0.034235, "average": 0.884648, "min": 0.430719}, "location": {"width": 283, "top": 1062, "height": 25, "left": 260}, "words": "对于年老的恶者应甲氨蝶呤"}, {"probability": {"variance": 0, "average": 0.999379, "min": 0.998555}, "location": {"width": 152, "top": 1125, "height": 25, "left": 219}, "words": "【药物相互作用】"}, {"probability": {"variance": 0, "average": 0.999837, "min": 0.999837}, "location": {"width": 106, "top": 1118, "height": 43, "left": 668}, "words": "有"}, {"probability": {"variance": 0.017662, "average": 0.935221, "min": 0.381434}, "location": {"width": 745, "top": 1156, "height": 32, "left": 243}, "words": "甲氨蝶呤吸收之后与血清门蛋门部分结合,由其结合能些药物替代例如水杨酸盐"}, {"probability": {"variance": 0.013954, "average": 0.946526, "min": 0.464826}, "location": {"width": 757, "top": 1186, "height": 36, "left": 240}, "words": "磺胺类药、磺脲、保泰松和苯妥英,故性反应可能会增加丙舒能减少肾小管的"}, {"probability": {"variance": 0.013759, "average": 0.939721, "min": 0.502253}, "location": {"width": 747, "top": 1217, "height": 36, "left": 242}, "words": "转运功能,因此,甲氨蝶吟与丙磺舒合用时应任细监测。降血脂化合物(例如考米烯胺)"}, {"probability": {"variance": 0.020931, "average": 0.912907, "min": 0.52775}, "location": {"width": 485, "top": 1249, "height": 29, "left": 241}, "words": "与甲氨蝶呤合川时,其结合甲氨蝶呤能力大于清蛋白"}, {"probability": {"variance": 0.019269, "average": 0.896582, "min": 0.569139}, "location": {"width": 751, "top": 1282, "height": 28, "left": 244}, "words": "青霉素利胺类药物川能降低甲氨螺呤的肾除率观察到甲氨蝶呤血清浓度增高并"}, {"probability": {"variance": 0.031545, "average": 0.883384, "min": 0.364836}, "location": {"width": 659, "top": 1311, "height": 30, "left": 241}, "words": "伴有血液学胃肠道每性。甲氨蝶呤与青霉素或收类药合用时应密切观察"}, {"probability": {"variance": 0.019582, "average": 0.935098, "min": 0.512556}, "location": {"width": 754, "top": 1342, "height": 33, "left": 242}, "words": "在骨肉瘤治疗中非体抗炎药物不应该在人剂量甲氨蝶呤给药之前或同时使用。有报道"}, {"probability": {"variance": 0.013927, "average": 0.953731, "min": 0.470367}, "location": {"width": 753, "top": 1373, "height": 34, "left": 242}, "words": "与大剂量甲氨蝶吟同时使用 NSAIDS能提高井延长甲氨蝶吟血清浓度,结果导致患者因为"}, {"probability": {"variance": 0.000385, "average": 0.986047, "min": 0.932674}, "location": {"width": 307, "top": 1407, "height": 24, "left": 241}, "words": "严重的血液学和胃肠道毒性而死亡"}, {"probability": {"variance": 0.018404, "average": 0.931011, "min": 0.378585}, "location": {"width": 752, "top": 1436, "height": 33, "left": 243}, "words": "当 NSAIDS和水杨酸盐与低剂能甲氨蝶呤同时使用时慎。有报道这些药物在某一动物"}, {"probability": {"variance": 0.013721, "average": 0.953684, "min": 0.412034}, "location": {"width": 520, "top": 1468, "height": 31, "left": 242}, "words": "模型中会降低甲氨蝶吟的肾小管分泌并任可能加重性作用"}, {"probability": {"variance": 0.02177, "average": 0.940902, "min": 0.361657}, "location": {"width": 727, "top": 1500, "height": 36, "left": 254}, "words": "己有报道甲氨蝶呤(通常大药)与某些 NSA ID)S包括河司匹林和其它水杨酸盐"}, {"probability": {"variance": 0.025399, "average": 0.907001, "min": 0.389424}, "location": {"width": 745, "top": 1531, "height": 34, "left": 250}, "words": "阿扎丙宗、一氯芬液,辛和洛芬同时给药时出现未预知的严重的(有时为致命"}, {"probability": {"variance": 0.007884, "average": 0.969142, "min": 0.552888}, "location": {"width": 743, "top": 1563, "height": 33, "left": 252}, "words": "的)骨髓抑制和胃肠道毒性:已有报道甲氧丙酸不会影响甲氨蝶岭的药代动力学,但"}], "language": 3}